Browse > Home / FDA News / FDA Warns Galderma Over Visual Aids

FDA Warns Galderma Over Visual Aids

September 4, 2009

FDA Warns Galderma Over Visual Aids
Galderma Laboratories overstated the efficacy of its Tri-Luma cream for the hide condition melasma in of the eye aids and minimized important risks, according to an Aug. 18 warning letter posted up not long ago to the FDA’sitting website. The agency’s Division of Drug Marketing, Advertising and Communications reviewed two professional visual aids for Tri-Luma (fluocinolone acetonide/hydroquinone/tretinoin), which is indicated for the treatment of moderate-to-severe melasma, or hyperpigmentation, of the face at what time a persevering is avoiding sun exposing. and using sunscreens. The visual aids were disseminated with unapproved product labeling that also included false and misleading claims, according to the letter.

Written by Samanta · Filed Under FDA News